More on Consumer Law and Elderly Victims

We posted yesterday on how the law should deal with consumer scams directed at older people in light of evidence that older people are more susceptible to deception. After the post, Ted Mermin, consumer-law expert and head of the Public Good Law Center, pointed out that some states' consumer protection statutes authorize greater penalties against […]

American Banker: Lobbying CFPB on Arbitration Intensifies

Here (login required).  An excerpt: Likewise, there was initially deep skepticism inside the banking industry about the CFPB's arbitration study, and there is still a belief among industry insiders that the agency's research is likely to lead to new regulations. * * * But over the last few months, industry observers have been relatively pleasedwith they […]

Kiva and Microlending

Over at Credit Slips, Alan White has a great post about what he loves about the microlending non-profit, Kiva. He then discusses microlending more generally. Kiva is "a non-profit organization with a mission to connect people through lending to alleviate poverty." "Leveraging the internet and a worldwide network of microfinance institutions," Kiva says, it "lets […]

Be Careful Buying a Used Car in the Wake of Hurricane Sandy

Bad floods damage a lot of cars, and then some used car sellers want to sell those damaged cars to unsuspecting customers without disclosing the damage. This happened after Katrina (go, for instance, go here and here). Holly Petreaus, the head of Servicemember Affairs at the Consumer Financial Protection Bureau, has posted this warning about used […]

Disclosure vs. Regulation

by Jeff Sovern Last week I had a very interesting conversation with a Ph.D candidate from the University of Amsterdam, Frederik J. Zuiderveen Borgesius, who is researching privacy regulation and behavioral targeting. He asked me if I could refer him to a book that explores when disclosure is an appropriate response to consumer protection problems […]

Supreme Court Grants Review in Pay-for-Delay Settlement Case

by Brian Wolfman In a pay-for-delay settlement, a brand-name drug company pays a generic company that has challenged the brand-name company's patent to stay out of the market. Some early antitrust challenges to these settlements succeeded, but later court of appeals' rulings gave them a green light. Then, as we discussed in this post last July, […]